Developer of an adaptive business operations platform intended to connect existing systems and projects and tailor experiences for each person. The company's platform abstracts the technical knowledge required to automate, monitor and manage mission-critical business processes, while still maintaining compliance and security, enabling enterprises to accelerate operational velocity at scale.
Developer of a cloud management platform designed to offer infrastructure as code architecture. The company's platform offers an environment for productivity, a custom ad-hoc environment for specialized tasks, and running end-to-end tests on each pull request, enabling developers to create and access a self-service work environment that would further reduce costs and increase the ease of work.
Developer of automation software intended for financial services, government, healthcare, business process outsourcing, and other markets. The company's platform offers business intelligence and analytic software services that combine content, process management, data integration, mobile, e-signature, and customer communications management, thereby helping organizations transform information-intensive business processes, reduce manual work and errors, minimize costs, and improve customer engagement.
Developer of a synthetic data generator platform designed to make data available and secure to customers, partners, and the law. The company's platform preserves the constraints, statistical correlations, distributions, and interdependencies that make a data set unique and unblocks analytics and software development by getting the user access to the data they crave without breaching customer trust or organizational policies, enabling developers, data scientists and salespeople to work conveniently without compromising on compliance and privacy.
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).
Developer and provider of scalable handwriting solutions designed to help users send handwritten notes. The company uses custom-designed handwriting robots that hold real pens to write out the notes in the handwriting style of the client's choice, address the envelope, and place it in the mail with a real stamp, thereby allowing consumers to exchange personalized letters in an efficient manner.